Cargando…

Eliminating residual iPS cells for safety in clinical application

Detalles Bibliográficos
Autores principales:	Masuda, Shigeo, Miyagawa, Shigeru, Fukushima, Satsuki, Sougawa, Nagako, Okimoto, Kaori, Tada, Chika, Saito, Atsuhiro, Sawa, Yoshiki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Higher Education Press 2015
Materias:	News and Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491051/ https://www.ncbi.nlm.nih.gov/pubmed/26040624 http://dx.doi.org/10.1007/s13238-015-0170-4

Ejemplares similares

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy
por: Sougawa, Nagako, et al.
Publicado: (2018)

Sustained-Release Delivery of Prostacyclin Analogue Enhances Bone Marrow-Cell Recruitment and Yields Functional Benefits for Acute Myocardial Infarction in Mice
por: Imanishi, Yukiko, et al.
Publicado: (2013)

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
por: Iseoka, Hiroko, et al.
Publicado: (2018)

Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells
por: Takeda, Maki, et al.
Publicado: (2018)

Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model
por: Kawamura, Masashi, et al.
Publicado: (2017)

Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype
por: Mori, Daisuke, et al.
Publicado: (2019)

Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy
por: Ohkawara, Hirotatsu, et al.
Publicado: (2018)

Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia
por: Umeda, Satoshi, et al.
Publicado: (2016)

Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart
por: Miyagawa, Shigeru, et al.
Publicado: (2016)

A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
por: Fukushima, Satsuki, et al.
Publicado: (2015)

Combined administration of laminin-221 and prostacyclin agonist enhances endogenous cardiac repair in an acute infarct rat heart
por: Sougawa, Nagako, et al.
Publicado: (2021)

Application of iPS cell-derived macrophages to cancer therapy
por: Senju, Satoru, et al.
Publicado: (2014)

Recent Clinical and Experimental Advances in Atrial Fibrillation
por: Miyagawa, Shigeru, et al.
Publicado: (2011)

Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction
por: Ishida, Masaru, et al.
Publicado: (2019)

Phase I Clinical Trial of Autologous Stem Cell–Sheet Transplantation Therapy for Treating Cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2017)

Influence of coronary architecture on the variability in myocardial infarction induced by coronary ligation in rats
por: Kainuma, Satoshi, et al.
Publicado: (2017)

Secondary abdominal compartment syndrome required decompression laparotomy during minimally invasive mitral valve repair
por: Nishi, Hiroyuki, et al.
Publicado: (2016)

Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model
por: Iseoka, Hiroko, et al.
Publicado: (2020)

Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice
por: Kawamura, Ai, et al.
Publicado: (2016)

Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model
por: Ito, Emiko, et al.
Publicado: (2023)

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
por: Ito, Emiko, et al.
Publicado: (2019)

TRPV-1-mediated elimination of residual iPS cells in bioengineered cardiac cell sheet tissues
por: Matsuura, Katsuhisa, et al.
Publicado: (2016)

N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Kawamura, Takuji, et al.
Publicado: (2014)

Tumor-free iPS stem cells for heart cells
por: Phillips, M Ian
Publicado: (2014)

Impact of microRNA Expression in Human Atrial Tissue in Patients with Atrial Fibrillation Undergoing Cardiac Surgery
por: Nishi, Hiroyuki, et al.
Publicado: (2013)

Engraftment and morphological development of vascularized human iPS cell-derived 3D-cardiomyocyte tissue after xenotransplantation
por: Narita, Hirokazu, et al.
Publicado: (2017)

Evaluation of right ventricular function using liver stiffness in patients with left ventricular assist device†
por: Kashiyama, Noriyuki, et al.
Publicado: (2017)

Development of a practical sandwich assay to detect human pluripotent stem cells using cell culture media
por: Tateno, Hiroaki, et al.
Publicado: (2017)

Functional and pathological characteristics of reversible remodeling in a canine right ventricle in response to volume overloading and volume unloading
por: Ishimaru, Kazuhiko, et al.
Publicado: (2014)

Skeletal Myoblast Cell Sheet Implantation Ameliorates Both Systolic and Diastolic Cardiac Performance in Canine Dilated Cardiomyopathy Model
por: Shirasaka, Tomonori, et al.
Publicado: (2016)

Xeno‐pericardial patch repair of the inferior vena cava for radical resection of renal cell carcinoma with tumor thrombus
por: Fukushima, Satsuki, et al.
Publicado: (2017)

Yes‐associated protein activation potentiates glycogen synthase kinase‐3 inhibitor‐induced proliferation of neonatal cardiomyocytes and iPS cell‐derived cardiomyocytes
por: Kametani, Yusuke, et al.
Publicado: (2022)

Questions Surrounding iPS Cells in Japan
por: Yui, Yoshiki
Publicado: (2016)

Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts
por: Kashiyama, Noriyuki, et al.
Publicado: (2019)

Comparison of Arrhythmogenicity and Proinflammatory Activity Induced by Intramyocardial or Epicardial Myoblast Sheet Delivery in a Rat Model of Ischemic Heart Failure
por: Pätilä, Tommi, et al.
Publicado: (2015)

Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells
por: Yoshida, Shohei, et al.
Publicado: (2018)

Redo coronary bypass grafting for congenital left main coronary atresia: a case report
por: Yajima, Shin, et al.
Publicado: (2017)

Tissue- and Plasma-Specific MicroRNA Signatures for Atherosclerotic Abdominal Aortic Aneurysm
por: Kin, Keiwa, et al.
Publicado: (2012)

Irradiation strongly reduces tumorigenesis of human induced pluripotent stem cells
por: Inui, Shoki, et al.
Publicado: (2017)

Publisher Correction: Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t09g7q2msrn94bbiomseonuu9u